672 related articles for article (PubMed ID: 10534516)
21. Long term follow-up of patients with chronic hepatitis C treated with interferon alpha.
Collier JD; Adams PA; Feinman V; Ghent C; Witt-Sullivan H; Minuk G; Krajden M; Heathcote J
Can J Gastroenterol; 2000; 14 Suppl B():77B-80B. PubMed ID: 10938510
[TBL] [Abstract][Full Text] [Related]
22. Early changes in hepatitis C virus (HCV) RNA levels predict response to interferon treatment in noncirrhotic HCV patients.
Fallows G; Kaita K; Minuk G; Penner F; Smart G; Dawood M; Rosser B
Can J Gastroenterol; 2000; 14 Suppl B():30B-35B. PubMed ID: 10938502
[TBL] [Abstract][Full Text] [Related]
23. Monotherapy with peginterferon alpha-2b {12 kDa} for chronic hepatitis C infection in patients undergoing haemodialysis.
Amarapurkar DN; Patel ND; Kirpalani AL
Trop Gastroenterol; 2007; 28(1):16-8. PubMed ID: 17896604
[TBL] [Abstract][Full Text] [Related]
24. Interferon therapy in hemodialysis patients with chronic hepatitis C: study of tolerance, efficacy and post-transplantation course.
Mahmoud IM; Sobh MA; El-Habashi AF; Sally ST; El-Baz M; El-Sawy E; Ghoneim MA
Nephron Clin Pract; 2005; 100(4):c133-9. PubMed ID: 15855796
[TBL] [Abstract][Full Text] [Related]
25. Outcome of kidney transplant in chronic hepatitis C virus patients: effect of pretransplantation interferon-alpha2b monotherapy.
González-Roncero F; Gentil MA; Valdivia MA; Algarra G; Pereira P; Toro J; Sayago M; Mateos J
Transplant Proc; 2003 Aug; 35(5):1745-7. PubMed ID: 12962779
[TBL] [Abstract][Full Text] [Related]
26. Safety and Efficacy of Pegylated Interferon Alpha-2b Monotherapy in Hepatitis C Virus-Infected Children with End-Stage Renal Disease on Hemodialysis.
Mogahed EA; Abdelaziz H; Helmy H; Ghita H; Abdel Mawla MA; Hassanin F; Fadel FI; El-Karaksy H
J Interferon Cytokine Res; 2016 Dec; 36(12):681-688. PubMed ID: 27656950
[TBL] [Abstract][Full Text] [Related]
27. Treatment with interferon-alpha2b of naive non-cirrhotic patients with chronic hepatitis C according to viraemia and genotype. Results of a randomized multicentre study. The North West Italian Hepatological Group.
Saracco G; Ciancio A; Ghisetti V; Rocca G; Cariti G; Andreoni M; Tabone M; Roffi L; Calleri G; Ballaré M; Terreni N; Sartori M; Tappero GF; Traverso A; Poggio A; Orani A; Maggi G; Di Napoli A; Arrigoni A; Rizzetto M;
Eur J Gastroenterol Hepatol; 2001 Feb; 13(2):149-55. PubMed ID: 11246614
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of interferon retreatment after relapse for chronic hepatitis C patients with biochemical response after first interferon therapy.
Arase Y; Ikeda K; Tsubota A; Suzuki Y; Saitoh S; Kobayashi M; Suzuki F; Akuta N; Someya T; Hosaka T; Kobayashi M; Kumada H
J Gastroenterol; 2004; 39(5):455-60. PubMed ID: 15175944
[TBL] [Abstract][Full Text] [Related]
29. Early addition of ribavirin to interferon in chronic hepatitis C not responsive to interferon monotherapy.
Bellobuono A; Mondazzi L; Tempini S; Chiodo F; Magliano E; Furione L; Idéo G
J Hepatol; 2000 Sep; 33(3):463-8. PubMed ID: 11020003
[TBL] [Abstract][Full Text] [Related]
30. Sustained virological and histological response with pretransplant interferon therapy in renal transplant patients with chronic viral hepatitis C.
Huraib S; Iqbal A; Tanimu D; Abdullah A
Am J Nephrol; 2001; 21(6):435-40. PubMed ID: 11799259
[TBL] [Abstract][Full Text] [Related]
31. Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferon-alpha therapy.
Marcellin P; Boyer N; Gervais A; Martinot M; Pouteau M; Castelnau C; Kilani A; Areias J; Auperin A; Benhamou JP; Degott C; Erlinger S
Ann Intern Med; 1997 Nov; 127(10):875-81. PubMed ID: 9382365
[TBL] [Abstract][Full Text] [Related]
32. Interferon treatment for hepatitis C virus infection in patients on haemodialysis.
Chan TM; Wu PC; Lau JY; Lok AS; Lai CL; Cheng IK
Nephrol Dial Transplant; 1997 Jul; 12(7):1414-9. PubMed ID: 9249778
[TBL] [Abstract][Full Text] [Related]
33. Safety and effectiveness of response-guided therapy using pegylated interferon and ribavirin for chronic hepatitis C virus infection in patients on maintenance dialysis.
Goel A; Bhadauria DS; Kaul A; Prasad N; Gupta A; Sharma RK; Rai P; Aggarwal R
Nephrology (Carlton); 2017 Sep; 22(9):706-711. PubMed ID: 27286895
[TBL] [Abstract][Full Text] [Related]
34. Clinical and virological features of chronic hepatitis C carriers with normal alanine aminotransferase levels despite positive serum HCV-RNA after interferon therapy.
Arase Y; Ikeda K; Chayama K; Murashima N; Tsubota A; Nakamura I; Suzuki Y; Saitoh S; Kobayashi M; Kobayashi M; Kobayashi M; Kumada H
J Gastroenterol; 1999 Oct; 34(5):594-9. PubMed ID: 10535487
[TBL] [Abstract][Full Text] [Related]
35. Effect of interferon-alpha induction therapy on genotype 2b/3a and low viral load hepatitis C virus infection. A randomized multicentre study.
Bjøro K; Bell H; Myrvang B; Skaug K; Raknerud N; Sandvei P; Størseth S; Ritland S; Lund-Tønnesen S; Bucher A; Hellum KB
Scand J Gastroenterol; 2002 Mar; 37(3):344-9. PubMed ID: 11916198
[TBL] [Abstract][Full Text] [Related]
36. Alpha-interferon therapy in chronic hepatitis due to active dual infection with hepatitis B and C viruses.
Guptan RC; Thakur V; Raina V; Sarin SK
J Gastroenterol Hepatol; 1999 Sep; 14(9):893-8. PubMed ID: 10535471
[TBL] [Abstract][Full Text] [Related]
37. Serum transaminase elevations during pegylated interferon treatment of chronic HCV hepatitis probably induced by polyethylene glycol.
Caroleo B; Gallelli L; Staltari O; De Sarro G; Guadagnino V
Intervirology; 2008; 51(6):407-9. PubMed ID: 19258719
[TBL] [Abstract][Full Text] [Related]
38. Histological and virological long-term outcome in patients treated with interferon-alpha2b and ribavirin for chronic hepatitis C.
Schvarcz R; Glaumann H; Reichard O; Weiland O
J Viral Hepat; 1999 May; 6(3):237-42. PubMed ID: 10607236
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of twice-daily administration of interferon-beta for chronic hepatitis C.
Kakizaki S; Takagi H; Yamada T; Ichikawa T; Abe T; Sohara N; Kosone T; Kaneko M; Takezawa J; Takayama H; Nagamine T; Mori M
J Viral Hepat; 1999 Jul; 6(4):315-9. PubMed ID: 10607246
[TBL] [Abstract][Full Text] [Related]
40. Treatment of chronic hepatitis C with peginterferon alfa-2b, plus ribavirin in end stage renal disease patients treated by hemodialysis: single Saudi center experience.
Alsaran K; Sabry A; Molhem A
Ren Fail; 2013; 35(10):1305-9. PubMed ID: 24059964
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
